. Author manuscript; available in PMC: 2014 Sep 19.

Published in final edited form as: Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006654. doi: 10.1002/14651858.CD006654.pub2

Analysis 5.26. Comparison 5 OLANZAPINE versus RISPERIDONE, Outcome 26 Adverse effects: 6. Haematological: white blood cells - significant low white blood cell count (as def. by the original studies).

Review: Olanzapine versus other atypical antipsychotics for schizophrenia

Comparison: 5 OLANZAPINE versus RISPERIDONE

Outcome: 26 Adverse effects: 6. Haematological: white blood cells - significant low white blood cell count (as def. by the original studies)